VIM carbapenemase (qPCR)

Log in to see the prices.

The price above is a net price.

Description

The VIM carbapenemase (qPCR) product is used to determine the sequence of genes encoding VIM carbapenemases in DNA preparations obtained from human material.

Product characteristics

Kit size: 100 markers

Reaction: duplex (FAM: VIM-group carbapenemases, HEX: internal control)

Internal control: exogenous/endogenous

Determination: qualitative/quantitative

Kit components:

  • Reaction mixture: contains DNA polymerase, probes and primers, and other qPCR reaction components;
  • Positive control;
  • Negative control;
  • PCR-grade water;
  • Internal control

VIM carbapenemases

The most common mechanism of resistance of Enterobacterales to carbapenems is the production of carbapenemases, which mainly include KPC, NDM, VIM, IMP, and OXA-48-like. Most of them are encoded on plasmids. Therefore, carbapenem resistance genes spread easily through horizontal gene transfer. Another less common mechanism of carbapenem resistance is the combination of extended-spectrum beta-lactamase (ESBL) or AmpC expression and porin loss or overexpression of efflux pumps. Carbapenem-resistant Enterobacterales (CRE) resulting from the first mechanism are referred to as carbapenemase-producing CRE (CP-CRE). Carbapenem-resistant Enterobacterales resulting from the second mechanism are referred to as non-carbapenemase-producing CRE (non-CP-CRE).

VIM carbapenemases belong to class B β-lactamases (MBL). The MBL class represents the most distinct evolutionary and structural lineage of these enzymes, and its functional specificity is most notable for its dependence on zinc ions and its natural ability to hydrolyze carbapenems. The substrate spectrum of the vast majority of MBLs is very broad and also includes penicillins and first- to fourth-generation cephalosporins.

The first gene encoding carbapenemase VIM (Verona Integron-Encoded Metallo-beta-lactamase) was identified at the end of 1997 in P. auregionas in Verona, Italy. Since then, over 69 variants of this gene have been described. VIM variants occur mainly in Pseudomonas, Acinetobacter, and Enterobacteriaceae species, which are found worldwide. In contrast, NDM carbapenemase was first identified in 2008 in a Klebsiella pneumoniae isolate taken from a Swedish patient hospitalized in India.

Files to download

Safety Data Sheet

Rivbio product catalog